glp 1 and migraines GLP-1 Drug Cuts Migraine Days in Half A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity chronic migraine. Participants reported an average Headache and GLP-1 receptor agonists:
Description
These medications enable cause-specific management of obesity complications.
Health Canada authorizes injection for treatment of adult patients with type 2 diabetes
There is no one-size-fits-all approach, and ongoing support can play a critical role in helping patients maintain their progress
Explore Fyrtles fertility-focused GLP-1 guidance, designed to support metabolic wellness and enhance your reproductive health
A new era for weight loss
